Salvage permanent perineal radioactive‐seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy
- 4 August 2009
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 104 (5) , 600-604
Abstract
OBJECTIVE: To assess our experience with salvage permanent perineal radioactive‐seed implantation (SPPI) as a possible therapeutic option for recurrent prostate adenocarcinoma, as salvage therapies for recurrences after definitive external beam radiotherapy (EBRT) for localized adenocarcinoma of the prostate are associated with significant morbidity and biochemical failure. PATIENTS AND METHODS: We retrospectively analysed on patients who had SPPI for localized recurrent prostate adenocarcinoma from 1996 to 2007 after primary treatment with EBRT. Excluded were patients who had other primary treatment or had no follow‐up. Primary outcomes were time to biochemical relapse‐free survival, using the Phoenix definition of a prostate‐specific antigen (PSA) nadir +2 ng/mL, and cancer‐specific survival. Secondary outcomes were the International Prostate Symptom Score (IPSS), the International Index of Erectile Function‐5 score (IIEF‐5), and complications based on Common Terminology Criteria for Adverse Events (version 3). RESULTS: In all, 37 patients had SPPI during this period; after applying inclusion and exclusion criteria, 24 remained for analysis. At the time of salvage therapy, the median time to the diagnosis of local recurrence was 49 months, the median PSA level was 3.36 ng/mL, the median PSA doubling time was 20 months, and all patients were clinically re‐staged at ≤T2 with negative transrectal ultrasonography and/or magnetic resonance spectroscopy. The original Gleason score was ≤6 in nine patients, 7 in eight and ≥8 in three (not recorded in two). The median follow‐up after SPPI was 30 months; the cancer‐free survival was 96% (one death) and biochemical relapse‐free survival was 88% (three patients). The PSA level was higher than the levels before SPPI at 3 months in all three failures, but lower in all 21 patients considered relapse‐free. Complications included one urethral stricture, one grade 3 rectal haemorrhage and five grade 2 gross haematuria that resolved with conservative management. Insufficient data were available to assess the IPSS or IIEF‐5 scores. CONCLUSION: With a short‐term follow‐up SPPI appears to provide excellent prostate cancer control with an acceptable rate of complications for patients with local recurrence of prostate cancer after EBRT. An extended follow‐up is necessary to determine the long‐term durability and safety of SPPI.Keywords
This publication has 14 references indexed in Scilit:
- Salvage prostate brachytherapy for localized prostate cancer failure after external beam radiation therapyBrachytherapy, 2008
- Management of prostate cancer recurrences after radiation therapy‐brachytherapy as a salvage optionCancer, 2007
- Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- MORBIDITY AND FUNCTIONAL OUTCOMES OF SALVAGE RADICAL PROSTATECTOMY FOR LOCALLY RECURRENT PROSTATE CANCER AFTER RADIATION THERAPYJournal of Urology, 2004
- Treatment of Organ Confined Prostate Cancer with Third Generation Cryosurgery: Preliminary Multicenter ExperienceJournal of Urology, 2003
- Salvage Cryosurgery for Recurrent Prostate Cancer After Radiation Therapy: A Seven-Year Follow-upClinical Prostate Cancer, 2003
- Salvage Cryotherapy for Recurrent Prostate Cancer After Radiotherapy: Variables Affecting Patient OutcomeJournal of Clinical Oncology, 2002
- SALVAGE RADICAL PROSTATECTOMY FOR RADIORECURRENT PROSTATE CANCER: : MORBIDITY REVISITEDJournal of Urology, 2000
- Permanent brachytherapy as salvage treatment for recurrent prostate cancerUrology, 1999
- Salvage brachytherapy for localized prostate cancer after radiotherapy failureUrology, 1999